GeneFerm Biotechnology Co., Ltd. (TPEX:1796)

GeneFerm Biotechnology Revenue

GeneFerm Biotechnology had revenue of 170.15M TWD in the quarter ending September 30, 2026, with 2.75% growth. This brings the company's total for the last twelve months to 669.49M, up 2.23% year-over-year. In the year 2025, GeneFerm Biotechnology had annual revenue of 677.10M with 29.92% growth. That makes GeneFerm Biotechnology the 33,758th largest company in the world by revenue and 1,751st in Taiwan.

• Revenue (ttm): 669.49M
• Revenue Growth: +2.23%
• P/S Ratio: 1.71
• Revenue / Employee: 4.65M
• Employees: 144
• Market Cap: 1.14B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Biotechnology 681.13M 100.0%

By Geography

Chart

• Taiwan 433.44M 64.0%
• United States 141.22M 20.9%
• Others 75.44M 11.1%
• China 27.00M 4.0%

Fiscal year ended Dec 31, 2025 See the full GeneFerm Biotechnology breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	677.10M	155.94M	29.92%
Dec 31, 2024	521.16M	-272.61M	-34.34%
Dec 31, 2023	793.77M	159.81M	25.21%
Dec 31, 2022	633.96M	111.63M	21.37%
Dec 31, 2021	522.33M	154.03M	41.82%

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error